Literature DB >> 24798519

Gallotannin is a DNA damaging compound that induces senescence independently of p53 and p21 in human colon cancer cells.

Racha Al-Halabi1,2, Raghida Abou Merhi1, Saritha Chakilam3, Chirine El-Baba3, Eva Hamade1, Pietro Di Fazio2, Matthias Ocker2, Regine Schneider-Stock3, Hala Gali-Muhtasib4.   

Abstract

The plant secondary metabolite gallotannin (GT) is the simplest hydrolyzable tannin shown to have anti-carcinogenic properties in several cell lines and to inhibit tumor development in different animal models. Here, we determined if GT induces senescence and DNA damage and investigated the involvement of p53 and p21 in this response. Using HCT116 human colon cancer cells wildtype for p53(+/+) /p21(+/+) and null for p53(+/+) /p21(-/-) or p53(-/-) /p21(+/+) , we found that GT induces senescence independently of p21 and p53. GT was found to increase the production of reactive oxygen species (ROS) by altering the redox balance in the cell, mainly by reducing the levels of glutathione and superoxide dismutase (SOD). Using the key antioxidants N-acetyl cysteine, dithiothreitol, SOD, and catalase, we showed that ROS were partially involved in the senescence response. Furthermore, GT-induced cell cycle arrest in S-phase in all HCT116 cell lines. At later time points, we noticed that p53 and p21 null cells escaped complete arrest and re-entered cell cycle provoking higher rates of multinucleation. The senescence induction by GT was irreversible and was accompanied by significant DNA damage as evidenced by p-H2AX staining. Our findings indicate that GT is an interesting anti colon cancer agent which warrants further study.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  anti-cancer; colon cancer; gallotannin; reactive oxygen species; senescence

Mesh:

Substances:

Year:  2014        PMID: 24798519     DOI: 10.1002/mc.22172

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  3 in total

1.  A 'synthetic-sickness' screen for senescence re-engagement targets in mutant cancer backgrounds.

Authors:  Claire J Cairney; Lauren S Godwin; Alan E Bilsland; Sharon Burns; Katrina H Stevenson; Lynn McGarry; John Revie; Jon D Moore; Ceri M Wiggins; Rebecca S Collinson; Clare Mudd; Elpida Tsonou; Mahito Sadaie; Dorothy C Bennett; Masashi Narita; Christopher J Torrance; W Nicol Keith
Journal:  PLoS Genet       Date:  2017-08-14       Impact factor: 5.917

2.  Comprehensive analysis of telomerase inhibition by gallotannin.

Authors:  Nikita Savelyev; Polina Baykuzina; Svetlana Dokudovskaya; Olga Lavrik; Maria Rubtsova; Olga Dontsova
Journal:  Oncotarget       Date:  2018-04-10

3.  Streptococcus gallolyticus abrogates anti-carcinogenic properties of tannic acid on low-passage colorectal carcinomas.

Authors:  Sonja Oehmcke-Hecht; Vanessa Mandl; Lukas Tim Naatz; Lara Dühring; Juliane Köhler; Bernd Kreikemeyer; Claudia Maletzki
Journal:  Sci Rep       Date:  2020-03-13       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.